AG 011

Drug Profile

AG 011

Alternative Names: AG011; IL-10 - Intrexon; Interleukin-10 - Intrexon; Lactococcus lactis expressing human interleukin-10; Lactococcus lactis secreting human interleukin-10

Latest Information Update: 05 Dec 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator ActoGeniX
  • Class Anti-inflammatories; Bacteria
  • Mechanism of Action Interleukin-10 replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Crohn's disease; Ulcerative colitis

Most Recent Events

  • 14 Jan 2014 Discontinued - Phase-I for Crohn's disease in European Union (PO)
  • 14 Jan 2014 Discontinued - Phase-I/II for Ulcerative colitis in Canada (PO)
  • 14 Jan 2014 Discontinued - Phase-I/II for Ulcerative colitis in European Union (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top